logo

Viatris Inc. (VTRS)



Trade VTRS now with
  Date
  Headline
8/8/2022 7:17:00 AM Viatris Inc. (VTRS) Declares Quarterly Dividend of $ 0.12, Record Date 8/24/2022
8/8/2022 7:15:48 AM Viatris Inc. (VTRS) Has Lowered Its 2022 Revenue Estimate To $16.2 - $16.7 Bln From $17.0 - $17.5 Bln
8/8/2022 7:14:15 AM Viatris Inc. Q2 Earnings Summary
8/8/2022 7:01:57 AM Viatris Q2 EPS $0.26 Vs Loss $0.23 Last Year
5/19/2022 7:07:30 AM Viatris And Biocon Biologics Announce Abevmy Is Now Available In Canada
5/9/2022 7:14:27 AM Viatris Inc. Q1 Earnings Summary
5/9/2022 7:13:41 AM Viatris Inc. (VTRS) Declares Quarterly Dividend of $ 0.12, Record Date 5/24/2022
5/9/2022 7:01:13 AM Viatris Q1 EPS $0.33 Vs Loss $0.86 Last Year
3/16/2022 7:34:57 AM Viatris Announces Receipt Of FDA Approval For Generic Version Of Symbicort Inhalation Aerosol, Breyna
2/28/2022 8:50:06 AM Biocon Biologics To Acquire Viatris' Biosimilars Assets For Up To $3.335 Bln In Stock And Cash